Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine-Fentanyl versus Ropivacaine-Sufentanil for post-cesarean analgesia duration
IRCT20210827052297N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Ropivacaine + fentanyl with Ropivacaine + sufentanil (2 arms). Primary endpoints: Duration of analgesia, Hemodynamic changes and 1 more. Started Sep 2021; status: completed.
02
Drugs
ropivacainefentanylsufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20210827052297N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210827052297N1.